ECRG4 and type 2 diabetes mellitus: Expression of ECRG4 in circulating leukocytes from IFG and T2DM patients was 60% (P = 0.0065) and 44% (P = 0.042) less than the level detected in healthy controls, respectively (Fig 6A).